Trial Information

A research study for patients who have been diagnosed with metastatic, castrate-resistant prostate cancer

A study to evaluate a new way of potentially treating prostate cancer using a new vaccine that may help cells from your own body to recognize and kill the cancer cells.

Patient Inclusion Criteria:

Men 18 – 85 years of age with documented asymptomatic or minimally symptomatic metastatic castrate-resistant prostate cancer
Life expectancy >1 year
Chemotherapy naïve
No significant cardiovascular disease
No contraindication for vaccinia immunization

Patient Exclusion Criteria:

Chemotherapy: Concomitant use of chemotherapy is not allowed during the Treatment phase (approximately 5 months) of this trial.
Anti-cancer radionuclides: Concomitant use of anti-cancer radionuclides is not allowed during the Treatment phase of this trial.
Secondary hormonal therapies: Concomitant use of supplementary hormonal treatments is not allowed during the Treatment phase of this trial.
Corticosteroids: Concomitant chronic use of systemic corticosteroids is not allowed during the Treatment phase of the study. The use of inhaled corticosteroids, nasal sprays, and topical creams for small body areas is allowed.

Joan Galbraith, Pharmacy Quality and Clinical Research Manager
St. Alexius Medical Center
900 East Broadway Avenue
Bismarck, ND 58501
Phone: 701-530-6954
Fax: 701-530-6970
Email: jgalbraith@primecare.org

View Map

Research Center Information: St. Alexius Medical Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.